Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIP Trial: Sitavig for Herpes Labialis
NCT00769314Phase 3Completed
- Sponsor
- Valerio Therapeutics
- Start
- May 2007
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 7
01
Overview
A Phase 3 trial of aciclovir in herpes labialis, sponsored by Valerio Therapeutics. Started May 2007; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00769314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769314.